Drugs / Monapiravir
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT05638672 Comparator | May 2023 → Jun 2024 | COVID-19 | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monapiravir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05638672 ↗ |